Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Byrnes currently holds 690,900 shares of eFFECTOR Therapeutics, Inc. (EFTR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Byrnes has been a net buyer of EFTR stock. They have purchased $63.0K and sold $0 worth of shares.
Michael Byrnes's most recent insider trade was on Jan 7, 2026, when they sold 690,900 shares at $0.00 per share.
Michael Byrnes serves as Executive at eFFECTOR Therapeutics, Inc. (EFTR). They have executed 17 insider transactions totaling $63.0K over their tenure at the company.
Michael Byrnes holds the position of Executive at eFFECTOR Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Michael Byrnes has shown a buying trading pattern, with $63.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Michael Byrnes was on Dec 11, 2017, when they sold $228.0K worth of OCRX shares. This transaction involved 150,000 shares at $1.52 per share.
Michael Byrnes currently owns 690,900 shares of eFFECTOR Therapeutics, Inc. (EFTR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Byrnes's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Byrnes has 17 Form 4 filings on record as an insider at eFFECTOR Therapeutics, Inc..
Set alerts for Michael Byrnes and 40,000+ other insiders.